AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals
Authors: Vaccher, E Spina, M Tirelli, U
Citation: E. Vaccher et al., Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals, EUR J CANC, 37(10), 2001, pp. 1306-1315
Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy
Authors: De Paoli, P Vaccher, E Tedeschi, R Caffau, C Zanussi, S Bortolin, MT Crepaldi, C Spina, M Tirelli, U
Citation: P. De Paoli et al., Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy, CANCER IMMU, 50(3), 2001, pp. 157-162
Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients
Authors: Spina, M Vaccher, E Juzbasic, S Milan, I Nasti, G Talamini, R Fasan, M Antinori, A Nigra, E Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients, CANCER, 92(1), 2001, pp. 200-206
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANC CYTOP, 91(1), 2001, pp. 155-163
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Authors: Vaccher, E Spina, M di Gennaro, G Talamini, R Nasti, G Schioppa, O Vultaggio, G Tirelli, U
Citation: E. Vaccher et al., Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma, CANCER, 91(1), 2001, pp. 155-163
Hodgkin's disease: Clinical presentation and treatment
Authors: Tirelli, U Vaccher, E Spina, M Carbone, A
Citation: U. Tirelli et al., Hodgkin's disease: Clinical presentation and treatment, CANC TREAT, 104, 2001, pp. 247-265
Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels
Authors: Zanussi, S Bortolin, MT Tirelli, U Nasti, G Vaccher, E Giacca, M De Paoli, P
Citation: S. Zanussi et al., Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels, J ACQ IMM D, 23(5), 2000, pp. 439-441
The EORTC quality of life questionnaire-head and neck 35 in Italian laryngectomized patients
Authors: Zotti, P Lugli, D Vaccher, E Vidotto, G Franchin, G Barzan, L
Citation: P. Zotti et al., The EORTC quality of life questionnaire-head and neck 35 in Italian laryngectomized patients, QUAL LIFE R, 9(10), 2000, pp. 1147-1153
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma
Authors: Carbone, A Cilia, AM Gloghini, A Capello, D Fassone, L Perin, T Rossi, D Canzonieri, V De Paoli, P Vaccher, E Tirelli, U Volpe, R Gaidano, G
Citation: A. Carbone et al., Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma, LEUKEMIA, 14(7), 2000, pp. 1301-1309
Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study
Authors: Nasti, G Errante, D Talamini, R Rizzardini, G Fasan, M Landonio, G Zeroli, C Chichino, G Nigra, E Vaccher, E Tirelli, U
Citation: G. Nasti et al., Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: Results of a phase II study, J CL ONCOL, 18(7), 2000, pp. 1550-1557
Epidemiological, biological and clinical features of HIV-related lymphomasin the era of highly active antiretroviral therapy
Authors: Tirelli, U Spina, M Gaidano, G Vaccher, E Franceschi, S Carbone, A
Citation: U. Tirelli et al., Epidemiological, biological and clinical features of HIV-related lymphomasin the era of highly active antiretroviral therapy, AIDS, 14(12), 2000, pp. 1675-1688
Stanford V regimen and concomitant highly active antiretroviral therapy isfeasible and active in patients with Hodgkin's disease and HIV infection
Authors: Spina, M Gabarre, J Fasan, M Vaccher, E Tirelli, U
Citation: M. Spina et al., Stanford V regimen and concomitant highly active antiretroviral therapy isfeasible and active in patients with Hodgkin's disease and HIV infection, AIDS, 14(10), 2000, pp. 1457-1458
Human immunodeficiency virus-associated Hodgkin's disease
Authors: Spina, M Vaccher, E Nasti, G Tirelli, U
Citation: M. Spina et al., Human immunodeficiency virus-associated Hodgkin's disease, SEMIN ONCOL, 27(4), 2000, pp. 480-488
Role of brain biopsy in the management of focal brain lesions in HIV-infected patients
Authors: Antinori, A Ammassari, A Luzzati, R Castagna, A Maserati, R Rizzardini, G Ridolfo, A Fasan, M Vaccher, E Landonio, G Scerrati, M Rocca, A Butti, G Nicolato, A Lazzarin, A Tirelli, U
Citation: A. Antinori et al., Role of brain biopsy in the management of focal brain lesions in HIV-infected patients, NEUROLOGY, 54(4), 2000, pp. 993-997
Elevated serum transforming growth factor beta 1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM
Authors: Xu, JW Ahmad, A Jones, JF Dolcetti, R Vaccher, E Prasad, U Menezes, J
Citation: Jw. Xu et al., Elevated serum transforming growth factor beta 1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM, J VIROLOGY, 74(5), 2000, pp. 2443-2446
Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases
Authors: Xu, JW Ahmad, A D'Addario, M Knafo, L Jones, JF Prasad, U Dolcetti, R Vaccher, E Menezes, J
Citation: Jw. Xu et al., Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases, J IMMUNOL, 164(5), 2000, pp. 2815-2822
Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases. (vol 164, pg 2815, 2000)
Authors: Xu, JW Ahmad, A D'Addario, M Knafo, L Jones, JF Prasad, U Dolcetti, R Vaccher, E Menezes, J
Citation: Jw. Xu et al., Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases. (vol 164, pg 2815, 2000), J IMMUNOL, 164(10), 2000, pp. 5532-5532
Lung carcinoma in 36 patients with human immunodeficiency virus infection
Authors: Tirelli, U Spina, M Sandri, S Serraino, D Gobitti, C Fasan, M Sinicco, A Garavelli, P Ridolfo, AL Vaccher, E
Citation: U. Tirelli et al., Lung carcinoma in 36 patients with human immunodeficiency virus infection, CANCER, 88(3), 2000, pp. 563-569
Non-AIDS-defining cancers in the HIV-infected patient
Authors: Vaccher, E Tirelli, U
Citation: E. Vaccher et U. Tirelli, Non-AIDS-defining cancers in the HIV-infected patient, BAS CLIN ON, 21, 2000, pp. 223-240
HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy
Authors: Vaccher, E di Gennaro, G Nasti, G Juzbasic, S Tirelli, U
Citation: E. Vaccher et al., HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy, J ACQ IMM D, 22(4), 1999, pp. 407-408
AIDS-associated Kaposi's sarcoma is more aggressive in women: A study of 54 patients
Authors: Nasti, G Serraino, D Ridolfo, A Antinori, A Rizzardini, G Zeroli, C Nigro, L Tavio, M Vaccher, E Tirelli, U
Citation: G. Nasti et al., AIDS-associated Kaposi's sarcoma is more aggressive in women: A study of 54 patients, J ACQ IMM D, 20(4), 1999, pp. 337-341
Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combinationwith antiretroviral therapy and primary use of G-CSF
Authors: Errante, D Gabarre, J Ridolfo, AL Rossi, G Nosari, AM Gisselbrecht, C Kerneis, Y Mazzetti, E Vaccher, E Talamini, R Carbone, A Tirelli, U
Citation: D. Errante et al., Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combinationwith antiretroviral therapy and primary use of G-CSF, ANN ONCOL, 10(2), 1999, pp. 189-195
Neoplastic complications of HIV infection
Authors: Spina, M Vaccher, E Carbone, A Tirelli, U
Citation: M. Spina et al., Neoplastic complications of HIV infection, ANN ONCOL, 10(11), 1999, pp. 1271-1286
The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996
Authors: Pezzotti, P Serraino, D Rezza, G Dal Maso, L Vaccher, E Lepri, AC Franceschi, S
Citation: P. Pezzotti et al., The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996, INT J EPID, 28(5), 1999, pp. 975-981
A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. (vol 20, pg 403, 1999)
Authors: Nasti, G Errante, D Santarossa, S Vaccher, E Tirelli, U
Citation: G. Nasti et al., A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. (vol 20, pg 403, 1999), DRUG SAFETY, 20(6), 1999, pp. 473-473
Risultati: 1-25 | 26-28